Health Care: Drugs

Nivalis Therapeutics Inc (NVLS: NASDAQ)

$17.86 n/a | n/a%
07/28/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 17.86
52 Week High 19.60
52 Week Low 14.07
Avg. Daily Vol. (Mil) 0.32
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 261.23
Shares Out (Mil) 14.63
Float (Mil) 13.43
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.30
Current Ratio 6.00
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 0.00
Price/Cash Flow -18.30
Per Share Data
Earnings -1.92
Sales 0.00
Book Value 0.00
Cash Flow -0.97
Business Summary
Nivalis Therapeutics Incis engaged in developing small molecule therapeutics for the treatment of diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease and certain cardiovascular disorders.
General Information
3122 Sterling Circle
Suite 200
Boulder, CO 80301
www.n30pharma.com
Industry : Drugs
Sector: Health Care
Employees: NA
CEO: Mr. Jon Congleton
Short Interest
Current Month (Mil) 0.02
Previous Month (Mil) 0.01
Short Interest Ratio (Days) 0.10
Management Effectiveness
Return on Equity n.a.
Return on Assets 0.00
Return on Investments n.a.
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NVLS

Latest NVLS Headlines from TheStreet

More Financial News for NVLS

Press Releases for NVLS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter